PeerPerspectives: Sharpening Your 2020 Vision for Common Adult Vaccines

Annually, 42,000 adults die from vaccine-preventable diseases. Adult vaccination rates fall short of the Healthy People 2020 goals, and recent trends and increases in vaccine-preventable diseases reflect the low vaccination rates among US adults. In this activity, 3 community-based physicians discuss 4 real-world patient cases related to adult vaccinations, as well as their own experiences with administering vaccines for influenza; pneumococcal disease; herpes zoster; and tetanus, diphtheria, and acellular pertussis (Tdap). Activity Chair, Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP, provides his perspective on these real-world patient cases and makes the final evidence-based recommendations. 

Faculty

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Chair, Division of Infectious Disease
Summa Health System, Akron, Ohio
Professor, Internal Medicine; Master Teacher; Chair, Infectious Disease Section Northeast Ohio Medical University, Rootstown, Ohio
Immediate Past President of the National Foundation for Infectious Diseases 

Presenters

Eugene Cullen, MD
Family Physician
Skyland Medical Group
Columbia, New Jersey

Christopher Flores, MD
Assistant Clinical Professor, Department of Family Medicine,
Loma Linda University School of Medicine,
Loma Linda, California
Vice-chair, California Academy of Family Physicians
Committee of Continuing Professional Development
Palm Desert, California

Jessica Irvine, DO
Family Practice Physician,
Greenbrier Physicians, Inc,
Greenbrier Valley Medical Center
Ronceverte, West Virginia

Target audience

This activity was developed for primary care physicians, pulmonologists, and endocrinologists. 

Learning Objectives

At the conclusion of this activity, participants should be better able to:

  • Detail the health implications of common vaccine-preventable infectious diseases, particularly in patients with chronic conditions
  • Summarize current Advisory Committee on Immunization Practices' recommendations for influenza, pneumococcal, herpes zoster, and tetanus, diphteria, and acellular pertussis (Tdap) vaccines
  • Implement evidence-based strategies to promote the appropriate use of influenza, pneumococcal, herpes zoster and Tdap vaccines among adult patients. 

Instructions

Complete these 5 easy steps to participate in this activity:

1)    Complete the pre-activity Clinical Impact Challenge quiz, which will allow you to compare your answers at the beginning of the activity to your post-activity answers. 
2)    Listen to the activity introduction by Dr. File.
3)    Click on each of the 4 cases to read the case presentation, listen to the community-based physicians' discussion about the case, and listen to Dr. File's final recommendations for the case.
4)    Listen to the activity conclusion by Dr. File.
5)    Complete the post-activity quiz and evaluation form.

This activity was supported by an educational grant from Merck & Co., Inc. 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
06/25/2015
Course expires: 
06/24/2016
Cost:
$0.00
Rating: 
5

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Accreditation Period

Course opens: 
06/25/2015
Course expires: 
06/24/2016

Price

Cost:
$0.00
Please login or register to take this course.